Brian Custer, PhD, MPH

Brian Custer, PhD, MPH

Associate Adjunct Professor Department of Laboratory Medicine; Associate Investigator, Blood Systems Research Institute
Laboratory Medicine
Epidemiology and Health Outcomes Research - BSRI
Specialty Areas
Transfusion Epidemiology
Health Economics Policy

Vitalant Research Institute
270 Masonic Avenue
San Francisco, CA 94118
United States

Research and Clinical Interests

My research is focused on the health economics and epidemiology of blood supply and transfusion medicine interventions throughout the world. My work encompasses risk factor assessment for infections in blood donors, adverse reactions in donors, blood utilization, and cost-effectiveness of blood safety interventions. I lead the cost-utility analysis subgroup of the International Society for Blood Transfusion working party on transfused transmitted infectious diseases, am a co-principal investigator for the UCSF/Blood Centers of the Pacific clinical site of the NHLBI Retroviral Epidemiology Donor Study II (REDS-II), and a co-investigator for REDS-II International component in Brazil.

Selected Publications
  • Agapova M, Busch MP, Custer B. Cost-effectiveness of screening the US blood supply for Trypanosoma cruzi. Transfusion. 2010 Oct;50(10):2220-32.
  • Edgren G, Kamper-Jørgensen M, Eloranta S, Rostgaard K, Custer B, Ullum H, Murphy EL, Busch MP, Reilly M, Melbye M, Hjalgrim H, Nyrén O. Duration of red blood cell storage and survival of transfused patients. Transfusion. 2010 Jun;50(6):1185-95.
  • Kamel H, Tomasulo P, Bravo M, Wiltbank T, Cusick R, James RC, Custer B. Delayed adverse reactions to blood donation. Transfusion. 2010 Mar;50(3):556-65.
  • Custer B, Kamel H, Kiely NE, Murphy EL, Busch MP. Associations between West Nile virus infection and symptoms reported by blood donors identified through nucleic acid test screening. Transfusion. 2009 Feb;49(2):278-88.
  • Custer B, Johnson ES, Sullivan SD, Hazlet TK, Ramsey SD, Murphy EL, Busch MP. Community blood supply model: development of a new model to assess the safety, sufficiency, and cost of the blood supply. Med Decis Making. 2005 Sep-Oct;25(5):571-82.
Additional Information